Literature DB >> 24659515

Consensus design of a NOD receptor leucine rich repeat domain with binding affinity for a muramyl dipeptide, a bacterial cell wall fragment.

Rachael Parker1, Ana Mercedes-Camacho, Tijana Z Grove.   

Abstract

Repeat proteins have recently emerged as especially well-suited alternative binding scaffolds due to their modular architecture and biophysical properties. Here we present the design of a scaffold based on the consensus sequence of the leucine rich repeat (LRR) domain of the NOD family of cytoplasmic innate immune system receptors. Consensus sequence design has emerged as a protein design tool to create de novo proteins that capture sequence-structure relationships and interactions present in nature. The multiple sequence alignment of 311 individual LRRs, which are the putative ligand-recognition domain in NOD proteins, resulted in a consensus sequence protein containing two internal and N- and C-capping repeats named CLRR2. CLRR2 protein is a stable, monomeric, and cysteine free scaffold that without any affinity maturation displays micromolar binding to muramyl dipeptide, a bacterial cell wall fragment. To our knowledge, this is the first report of direct interaction of a NOD LRR with a physiologically relevant ligand.
© 2014 The Protein Society.

Entities:  

Keywords:  MDP; NOD; binding scaffold; consensus design; leucine rich repeat; repeat protein

Mesh:

Substances:

Year:  2014        PMID: 24659515      PMCID: PMC4093954          DOI: 10.1002/pro.2461

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  53 in total

Review 1.  The leucine-rich repeat as a protein recognition motif.

Authors:  B Kobe; A V Kajava
Journal:  Curr Opin Struct Biol       Date:  2001-12       Impact factor: 6.809

Review 2.  Consensus design of repeat proteins.

Authors:  Patrik Forrer; H Kaspar Binz; Michael T Stumpp; Andreas Plückthun
Journal:  Chembiochem       Date:  2004-02-06       Impact factor: 3.164

Review 3.  Computation and analysis of protein circular dichroism spectra.

Authors:  Narasimha Sreerama; Robert W Woody
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

Review 4.  Engineered protein scaffolds as next-generation antibody therapeutics.

Authors:  Michaela Gebauer; Arne Skerra
Journal:  Curr Opin Chem Biol       Date:  2009-06-06       Impact factor: 8.822

5.  Pathogen recognition in the innate immune response.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

6.  Redesign of a protein-peptide interaction: characterization and applications.

Authors:  Meredith E Jackrel; Roberto Valverde; Lynne Regan
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

7.  Thermodynamics, kinetics, and salt dependence of folding of YopM, a large leucine-rich repeat protein.

Authors:  Ellen Kloss; Doug Barrick
Journal:  J Mol Biol       Date:  2008-09-04       Impact factor: 5.469

8.  Designing repeat proteins: modular leucine-rich repeat protein libraries based on the mammalian ribonuclease inhibitor family.

Authors:  Michael T Stumpp; Patrik Forrer; H Kaspar Binz; Andreas Plückthun
Journal:  J Mol Biol       Date:  2003-09-12       Impact factor: 5.469

Review 9.  The repertoire of glycan determinants in the human glycome.

Authors:  Richard D Cummings
Journal:  Mol Biosyst       Date:  2009-07-28

Review 10.  Ligand binding by repeat proteins: natural and designed.

Authors:  Tijana Z Grove; Aitziber L Cortajarena; Lynne Regan
Journal:  Curr Opin Struct Biol       Date:  2008-07-23       Impact factor: 6.809

View more
  10 in total

Review 1.  A designed repeat protein as an affinity capture reagent.

Authors:  Elizabeth B Speltz; Rebecca S H Brown; Holly S Hajare; Christian Schlieker; Lynne Regan
Journal:  Biochem Soc Trans       Date:  2015-10       Impact factor: 5.407

2.  Computational design of a leucine-rich repeat protein with a predefined geometry.

Authors:  Sebastian Rämisch; Ulrich Weininger; Jonas Martinsson; Mikael Akke; Ingemar André
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-26       Impact factor: 11.205

3.  Structural Insights into VLR Fine Specificity for Blood Group Carbohydrates.

Authors:  Bernard C Collins; Robin J Gunn; Tanya R McKitrick; Richard D Cummings; Max D Cooper; Brantley R Herrin; Ian A Wilson
Journal:  Structure       Date:  2017-10-05       Impact factor: 5.006

4.  The use of consensus sequence information to engineer stability and activity in proteins.

Authors:  Matt Sternke; Katherine W Tripp; Doug Barrick
Journal:  Methods Enzymol       Date:  2020-07-17       Impact factor: 1.600

Review 5.  COPs and POPs Patrol Inflammasome Activation.

Authors:  Mohanalaxmi Indramohan; Christian Stehlik; Andrea Dorfleutner
Journal:  J Mol Biol       Date:  2017-10-10       Impact factor: 5.469

6.  Designed leucine-rich repeat proteins bind two muramyl dipeptide ligands.

Authors:  Christina S Kim; Anne M Brown; Tijana Z Grove; Felicia A Etzkorn
Journal:  Protein Sci       Date:  2021-02-15       Impact factor: 6.725

7.  A general computational approach for repeat protein design.

Authors:  Fabio Parmeggiani; Po-Ssu Huang; Sergey Vorobiev; Rong Xiao; Keunwan Park; Silvia Caprari; Min Su; Jayaraman Seetharaman; Lei Mao; Haleema Janjua; Gaetano T Montelione; John Hunt; David Baker
Journal:  J Mol Biol       Date:  2014-11-14       Impact factor: 5.469

8.  Control of repeat-protein curvature by computational protein design.

Authors:  Keunwan Park; Betty W Shen; Fabio Parmeggiani; Po-Ssu Huang; Barry L Stoddard; David Baker
Journal:  Nat Struct Mol Biol       Date:  2015-01-12       Impact factor: 15.369

Review 9.  Consensus protein design.

Authors:  Benjamin T Porebski; Ashley M Buckle
Journal:  Protein Eng Des Sel       Date:  2016-06-05       Impact factor: 1.650

10.  Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.

Authors:  Carles Vilariño-Güell; Alexander Zimprich; Filippo Martinelli-Boneschi; Bruno Herculano; Zhe Wang; Fuencisla Matesanz; Elena Urcelay; Koen Vandenbroeck; Laura Leyva; Denis Gris; Charbel Massaad; Jacqueline A Quandt; Anthony L Traboulsee; Mary Encarnacion; Cecily Q Bernales; Jordan Follett; Irene M Yee; Maria G Criscuoli; Angela Deutschländer; Eva M Reinthaler; Tobias Zrzavy; Elisabetta Mascia; Andrea Zauli; Federica Esposito; Antonio Alcina; Guillermo Izquierdo; Laura Espino-Paisán; Jorge Mena; Alfredo Antigüedad; Patricia Urbaneja-Romero; Jesús Ortega-Pinazo; Weihong Song; A Dessa Sadovnick
Journal:  PLoS Genet       Date:  2019-06-06       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.